Skip to main content
. 2022 Jan 30;9:20499361211073248. doi: 10.1177/20499361211073248

Table 2.

Source of bloodstream infection and microbiology.

IV group (n = 146) PO group (n = 98) p value
Community-acquired, n (%) 127 (87.0) 92 (93.9) 0.08
Polymicrobial Blood Culture 24 (16.4) 11 (11.2) 0.25
Source of bloodstream infection, n (%)
 Pneumonia 26 (17.8) 28 (28.6) 0.06
 Skin and soft tissue infections 31 (21.2) 14 (14.3) 0.18
 Intra-abdominal infections 29 (19.9) 11 (11.2) 0.08
 Urinary 6 (4.0) 7 (7.1) 0.39
 Ear–nose–throat infections 5 (3.4) 2 (2.0) 0.71
 Surgical manipulation 2 (1.4) 0 (0) 0.52
 Catheter-associated 1 (0.7) 1 (1.0) >0.99
 Other 4 (2.7) 14 (14.3) <0.01
 Unknown 42 (28.8) 21 (21.4) 0.23
Microbiology, n (%)
 Viridans group streptococcus 37 (25.3) 22 (22.4) 0.65
Streptococcus pneumoniae 22 (15.1) 25 (25.5) 0.05
Streptococcus agalactiae (group B) 27 (18.5) 13 (13.3) 0.30
Streptococcus pyogenes (group A) 23 (15.8) 17 (17.3) 0.86
Streptococcus anginosus 8 (5.5) 9 (9.2) 0.31
Streptococcus mitis/oralis 10 (6.8) 1 (1.0) 0.05
Streptococcus gallolyticus 6 (4.1) 2 (2.0) 0.48
Streptococcus constellatus 2 (1.4) 5 (5.1) 0.12
Streptococcus, beta hemolytic (not group A, B, or D) 4 (2.7) 0 (0) 0.15

IV, intravenous; PO, oral.